申请人:Rigel Pharmaceuticals, Inc.
公开号:US10377742B2
公开(公告)日:2019-08-13
Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure
wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
所公开的是取代的吡啶化合物以及药物组合物和使用方法。其中一种化合物具有如下结构
其中 E、J、T、以 "B "表示的环系、T、R3、R4、w 和 x 如本文所述。在某些实施方案中,本文公开的化合物可激活 AMPK 通路,并可用于治疗与代谢相关的疾病和病症。